...
Real World Data Autumn Event – Call For Speakers | ||
|---|---|---|
We’re excited to announce Call for Speakers for the Real World Evidence Working Group’s second multi‑day virtual event is now open! Taking place 30 September – 1 October 2026, from 09:00–11:30 (EDT) / 14:00–16:30 (BST) / 15:00–17:30 (CEST). Submit your abstract by 8 May for the chance to present. Focus your submission on these central themes:
Click here for more information.
|
...
Optimizing the Use of Data Standards
...
‘CTCAE Upversioning – When should a sponsor organisation decide to upversion CTCAE, DAIDS, or any other toxicity grading standards? How should sponsors handle pooled analyses with varying grading scales?'
Do you have a (FAQ project based) question? Send your questions to the team by emailing workinggroups@phuse.global.
...
Framework for Integrating Omics Data with Other Clinical and Non-Clinical Data Sources |
|---|
The Integration of Omics Data into Clinical Drug Development project within the Emerging Trends & Innovation Working Group has published a new white paper, Framework for Integrating Omics Data with Other Clinical and Non-Clinical Data Sourceswhich is now open for public review. This white paper proposes a framework for integrating multi-omics data with clinical and non-clinical datasets, combining BioCompute for workflow documentation and MultiAssayExperiment (MAE) for data management. It aims to improve standardisation, interoperability, and reproducibility to better support personalised medicine and regulatory use. The team welcome feedback on the paper by 31 March . Please send responses to workinggroups@phuse.global. |
...